Literature DB >> 26080342

Noninferiority Trials: Is a New Treatment Almost as Effective as Another?

Amy H Kaji1, Roger J Lewis2.   

Abstract

Mesh:

Year:  2015        PMID: 26080342     DOI: 10.1001/jama.2015.6645

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  15 in total

1.  Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia.

Authors:  Jien-Wei Liu; Yen-Hsu Chen; Wen-Sen Lee; Jung-Chung Lin; Ching-Tai Huang; Hsi-Hsun Lin; Yung-Ching Liu; Yin-Ching Chuang; Hung-Jen Tang; Yao-Shen Chen; Wen-Chien Ko; Min-Chi Lu; Fu-Der Wang
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

2.  Can Appealing to Patient Altruism Reduce Overuse of Health Care Services? An Experimental Survey.

Authors:  Kevin R Riggs; Peter A Ubel; Brendan Saloner
Journal:  J Gen Intern Med       Date:  2017-02-02       Impact factor: 5.128

3.  Design and interpretation of non-inferiority studies: A clinician's perspective.

Authors:  Todd M Brown
Journal:  J Nucl Cardiol       Date:  2017-08-10       Impact factor: 5.952

Review 4.  Sodium-glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus.

Authors:  Bianca Hemmingsen; Jesper Krogh; Maria-Inti Metzendorf; Bernd Richter
Journal:  Cochrane Database Syst Rev       Date:  2016-04-21

5.  Effect of High-Flow Nasal Cannula Therapy vs Continuous Positive Airway Pressure Therapy on Liberation From Respiratory Support in Acutely Ill Children Admitted to Pediatric Critical Care Units: A Randomized Clinical Trial.

Authors:  Padmanabhan Ramnarayan; Alvin Richards-Belle; Laura Drikite; Michelle Saull; Izabella Orzechowska; Robert Darnell; Zia Sadique; Julie Lester; Kevin P Morris; Lyvonne N Tume; Peter J Davis; Mark J Peters; Richard G Feltbower; Richard Grieve; Karen Thomas; Paul R Mouncey; David A Harrison; Kathryn M Rowan
Journal:  JAMA       Date:  2022-07-12       Impact factor: 157.335

6.  Effect of High-Flow Nasal Cannula Therapy vs Continuous Positive Airway Pressure Following Extubation on Liberation From Respiratory Support in Critically Ill Children: A Randomized Clinical Trial.

Authors:  Padmanabhan Ramnarayan; Alvin Richards-Belle; Laura Drikite; Michelle Saull; Izabella Orzechowska; Robert Darnell; Zia Sadique; Julie Lester; Kevin P Morris; Lyvonne N Tume; Peter J Davis; Mark J Peters; Richard G Feltbower; Richard Grieve; Karen Thomas; Paul R Mouncey; David A Harrison; Kathryn M Rowan
Journal:  JAMA       Date:  2022-04-26       Impact factor: 157.335

7.  Effect of Oral Moxifloxacin vs Intravenous Ertapenem Plus Oral Levofloxacin for Treatment of Uncomplicated Acute Appendicitis: The APPAC II Randomized Clinical Trial.

Authors:  Suvi Sippola; Jussi Haijanen; Juha Grönroos; Tero Rautio; Pia Nordström; Tuomo Rantanen; Tarja Pinta; Imre Ilves; Anne Mattila; Jukka Rintala; Eliisa Löyttyniemi; Saija Hurme; Ville Tammilehto; Harri Marttila; Sanna Meriläinen; Johanna Laukkarinen; Eeva-Liisa Sävelä; Heini Savolainen; Tomi Sippola; Markku Aarnio; Hannu Paajanen; Paulina Salminen
Journal:  JAMA       Date:  2021-01-26       Impact factor: 56.272

Review 8.  Non-inferiority trials: are they inferior? A systematic review of reporting in major medical journals.

Authors:  Sunita Rehal; Tim P Morris; Katherine Fielding; James R Carpenter; Patrick P J Phillips
Journal:  BMJ Open       Date:  2016-10-07       Impact factor: 2.692

Review 9.  Methods of defining the non-inferiority margin in randomized, double-blind controlled trials: a systematic review.

Authors:  Turki A Althunian; Anthonius de Boer; Olaf H Klungel; Widya N Insani; Rolf H H Groenwold
Journal:  Trials       Date:  2017-03-07       Impact factor: 2.279

10.  Noninferior Antibiotics: When Is "Not Bad" "Good Enough"?

Authors:  Mark J DiNubile
Journal:  Open Forum Infect Dis       Date:  2016-05-25       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.